Fig. 4From: Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO studyThe mean changes in treatment satisfaction score for one year. Patient satisfaction questionnaire assessments were performed with a Likert scale model with five questions. Mean change in the satisfaction score from baseline was − 1.11 at 3 months (p = 0.54) and − 2.47 at 12 months (p = 0.22)Back to article page